Texas 2023 - 88th Regular

Texas Senate Bill SB773

Filed
2/7/23  
Out of Senate Committee
4/19/23  
Voted on by Senate
4/27/23  
Out of House Committee
5/9/23  
Voted on by House
5/12/23  
Governor Action
6/18/23  

Caption

Relating to access to certain investigational drugs, biological products, and devices used in clinical trials by patients with severe chronic diseases.

Impact

If passed, SB773 would amend several state statutes related to gun ownership and sales, enforcing stricter protocols for background checks. This would necessitate changes in the processes that sellers must follow before completing firearm transactions. The bill aims to fill perceived gaps in current regulations, ensuring that all potential gun purchasers undergo thorough vetting to enhance community safety.

Summary

SB773 aims to introduce significant amendments to existing firearm regulations in the state. The bill proposes to tighten background check requirements for firearm purchases, emphasizing enhanced safety measures. Proponents argue that these changes are necessary to reduce gun-related incidents and enhance public safety. They believe that stricter regulations can help prevent firearms from falling into unsafe hands, particularly for individuals with a history of violent behavior or mental health issues.

Sentiment

The sentiment surrounding SB773 is deeply divided among lawmakers and the public. Supporters see the bill as a proactive step toward addressing gun violence and protecting citizens, while opponents argue that it infringes on Second Amendment rights. Many opponents claim that the bill will unfairly penalize law-abiding citizens and is a step toward more extensive gun control measures that could limit personal freedoms.

Contention

A significant point of contention regarding SB773 is the balance between ensuring public safety and protecting individual rights. Critics of the bill express concern that while the intent may be noble, its implementation could lead to ineffective measures that do not substantially reduce crime but rather complicate the legal landscape for responsible gun owners. The debates highlight broader concerns over gun control in the state, making it a crucial issue for both sides of the legislative aisle.

Texas Constitutional Statutes Affected

Occupations Code

  • Chapter 164. Disciplinary Actions And Procedures
    • Section: New Section
    • Section: New Section
    • Section: New Section

Insurance Code

  • Chapter 1379. Coverage For Routine Patient Care Costs For Enrollees Participating In Certain Clinical Trials
    • Section: New Section
    • Section: New Section
    • Section: New Section
    • Section: New Section

Companion Bills

TX HB638

Similar Relating to access to certain investigational drugs, biological products, and devices used in clinical trials by patients with severe chronic diseases.

Similar Bills

CA SB708

Public Utilities Commission: quorum for the transaction of business.

TX HB1502

Relating to the creation of the child and adult protective investigations advisory committee in the Department of Family and Protective Services.

TX SB425

Relating to the creation of the child and adult protective investigations advisory committee in the Department of Family and Protective Services.

TX HB140

Relating to the creation of the child and adult protective investigations advisory committee in the Department of Family and Protective Services.

ME LD417

An Act Regarding the Confidentiality of Certain Records Belonging to the Department of Agriculture, Conservation and Forestry Related to the Bureau of Forestry

TX HB2908

Relating to authorizing patients with certain terminal illnesses and severe chronic diseases to access certain investigational drugs, biological products, and devices that are in clinical trials.

TX HB638

Relating to access to certain investigational drugs, biological products, and devices used in clinical trials by patients with severe chronic diseases.

TX HB805

Relating to access to certain investigational drugs, biological products, and devices that are in clinical trials by patients with severe chronic diseases.